Migraine

The Pharmacy Times® Migraine Resource Center is a comprehensive resource for clinical news and expert insights on treatments for migraine headaches, which can cause severe throbbing pain or a pulsing sensation.

Latest News

Young girl with migraine -- Image credit: Gecko Studio | stock.adobe.com
Fremanezumab-vfrm Approved by FDA for Preventive Treatment of Episodic Migraine in Children, Adolescents

August 6th 2025

The FDA approved fremanezumab for pediatric migraine prevention, offering a new treatment option for children and adolescents aged 6 to 17 years.

Chronic headache, migraine | Image Credit: Serega | stock.adobe.com
Breaking New Ground in Migraine Prevention: Eptinezumab-jjmr

July 2nd 2025

X-ray image depicting a migraine -- Image credit: peterschreiber.media | stock.adobe.com
FDA Approves Brekiya, First and Only DHE Autoinjector, for Acute Treatment of Migraine, Cluster Headaches

May 15th 2025

Woman experiencing migraine-related pain -- Image credit: goodluz | stock.adobe.com
FDA Approves Atzumi, Nasal Powder Formulation of DHE, for Acute Treatment of Migraine

May 1st 2025

Woman with a migraine -- Image credit: BillionPhotos.com | stock.adobe.com
Migraine With Aura Plays Most Prominent Role in Women With Young-Onset CIS

April 21st 2025

Latest CME Events & Activities
<12345